Group One Trading’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100
Closed -$590 8988
2025
Q2
$590 Buy
+100
New +$529 ﹤0.01% 7636
2024
Q2
Sell
-1,400
Closed -$11.9K 7331
2024
Q1
$11.9K Hold
1,400
﹤0.01% 5771
2023
Q4
$11.9K Buy
1,400
+1,300
+1,300% +$12.3K ﹤0.01% 6090
2023
Q3
$1.02K Sell
100
-5,600
-98% -$58.1K ﹤0.01% 7212
2023
Q2
$74.2K Buy
5,700
+5,100
+850% +$63.3K ﹤0.01% 4924
2023
Q1
$5.57K Buy
+600
New +$6.94K ﹤0.01% 6236
2022
Q3
Sell
-100
Closed -$1K 8080
2022
Q2
$1K Buy
+100
New +$791 ﹤0.01% 7604
2022
Q1
Sell
-100
Closed -$1K 8538
2021
Q4
$1K Sell
100
-18,300
-99% -$229K ﹤0.01% 8011
2021
Q3
$269K Buy
+18,400
New +$280K ﹤0.01% 4863

Other funds holding PROF

Group One Trading's PROF Position: Q4 2025 in Review

Group One Trading sold out of Profound Medical (PROF) in Q4 2025, closing a stake of 150 shares — an estimated $747 sold.

Group One Trading first reported a position in PROF in Q3 2021 and held it in 10 quarters. The position peaked at $1.9K in Q4 2022. 63 funds tracked by Wall St. Rank hold PROF as of Q4 2025.

  • Group One Trading reported no remaining Profound Medical position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 150 Profound Medical shares in Q4 2025, an estimated $747.
  • Group One Trading first reported a position in Profound Medical in Q3 2021 and held it in 10 quarters.
  • Group One Trading's Profound Medical position peaked at $1.9K in Q4 2022.
  • 63 funds tracked by Wall St. Rank held Profound Medical as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.